Literature DB >> 8204604

Binding and state of aggregation of spin-labeled cecropin AD in phospholipid bilayers: effects of surface charge and fatty acyl chain length.

H S Mchaourab1, J S Hyde, J B Feix.   

Abstract

The binding and state of aggregation of cecropin in large unilamellar vesicles of different surface potential and varying acyl chain length were examined using a Cys-33 spin-labeled derivative of cecropin AD (CAD). Association isotherms of the peptide were measured for vesicles of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) containing 5, 15, and 30 mol % 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol (POPG). The isotherms display a concentration-dependent positive cooperativity indicating the possible formation of cecropin aggregates in the lipid phase. The critical aqueous concentration for aggregation was dependent on the fraction of POPG, suggesting the involvement of acidic lipids in the formation and stabilization of the putative aggregate. Our data also indicate that cooperativity depends on the state of side-chain ionization of an acidic residue that titrates between pH 7 and 4.4. The binding of spin-labeled Cys-33 CAD was found to be influenced by the acyl chain length of the host lipid. The association isotherm of the peptide for dilaureoyl-sn-glycero-3-phosphatidylcholine vesicles containing 30 mol % dilauroyl-sn-glycero-3-phosphatidylglycerol (DLPG) differed significantly from that in POPC/POPG and could be interpreted in terms of a monomer-monomer partitioning between the aqueous and lipid phases. ESR line-shape analysis was consistent with peptide aggregation in dioleoyl-sn-glycero-3-phosphatidylglycerol vesicles but not in DLPG vesicles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8204604     DOI: 10.1021/bi00187a040

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Antibacterial and antimembrane activities of cecropin A in Escherichia coli.

Authors:  L Silvestro; J N Weiser; P H Axelsen
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Spin-label oximetry at Q- and W-band.

Authors:  W K Subczynski; L Mainali; T G Camenisch; W Froncisz; J S Hyde
Journal:  J Magn Reson       Date:  2011-01-08       Impact factor: 2.229

3.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

4.  Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study.

Authors:  Kalpana Bhargava; Jimmy B Feix
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

Review 5.  Applications of biological pores in nanomedicine, sensing, and nanoelectronics.

Authors:  Sheereen Majd; Erik C Yusko; Yazan N Billeh; Michael X Macrae; Jerry Yang; Michael Mayer
Journal:  Curr Opin Biotechnol       Date:  2010-06-18       Impact factor: 9.740

6.  Preparation and characterization of a biologically active spin-labeled sea anemone toxin.

Authors:  S A Monks; R S Norton; C C Curtain; L J Berliner
Journal:  J Protein Chem       Date:  1996-07

7.  Peptide-Membrane Interactions by Spin-Labeling EPR.

Authors:  Tatyana I Smirnova; Alex I Smirnov
Journal:  Methods Enzymol       Date:  2015-09-26       Impact factor: 1.600

8.  Membrane lysis by the antibacterial peptides cecropins B1 and B3: A spin-label electron spin resonance study on phospholipid bilayers.

Authors:  S C Hung; W Wang; S I Chan; H M Chen
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

9.  Immobilization of Escherichia coli cells by use of the antimicrobial peptide cecropin P1.

Authors:  Kalvin Gregory; Charlene M Mello
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

10.  The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.

Authors:  Mark J Mannis
Journal:  Trans Am Ophthalmol Soc       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.